Intensity Therapeutics, Inc.
INTS
$0.41
$0.0515.05%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.37% | -3.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.04% | -20.30% | |||
| Operating Income | -1.04% | 20.30% | |||
| Income Before Tax | -5.28% | 24.20% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.28% | 24.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.28% | 24.20% | |||
| EBIT | -1.04% | 20.30% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 53.83% | 39.03% | |||
| Normalized Basic EPS | 53.81% | 39.09% | |||
| EPS Diluted | 53.83% | 39.03% | |||
| Normalized Diluted EPS | 53.81% | 39.09% | |||
| Average Basic Shares Outstanding | 128.12% | 24.35% | |||
| Average Diluted Shares Outstanding | 128.12% | 24.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||